Cobenfy (KarXT) approved by the EMA by June 30, 2025? | Binary | | | 3 months ago | |
Cobenfy (KarXT) commercially available in the U.S. by December 31, 2024? | Binary | | | 3 months ago | |
What will be Cobenfy's market share among schizophrenia treatments by the end of 2025? | Categorical | | | 3 months ago | |
Will Cobenfy receive a black box warning from the FDA by the end of 2025? | Binary | | | 3 months ago | |
Will Bristol Myers Squibb's stock price increase by more than 10% by the end of 2024? | Binary | | | 3 months ago | |
Will Cobenfy achieve $1 billion in sales by the end of 2025? | Binary | | | 3 months ago | |
What will Cobenfy's market share among schizophrenia treatments be by end of 2025? | Categorical | | | 3 months ago | |
Will Cobenfy achieve FDA fast-track designation for another indication by end of 2024? | Binary | | | 3 months ago | |
Will Cobenfy reach $1 billion in sales by the end of 2025? | Binary | | | 3 months ago | |
How many new schizophrenia drugs will FDA approve by end of 2025? | Categorical | | | 3 months ago | |
Cobenfy (KarXT) generate over $1 billion in sales by the end of 2025? | Binary | | | 3 months ago | |
What will be the peak annual sales of Cobenfy by the end of 2025? | Categorical | | | 3 months ago | |
How many new schizophrenia treatments will be approved by the FDA by the end of 2025? | Categorical | | | 3 months ago | |
Will Cobenfy receive a negative safety review from FDA by end of 2024? | Binary | | | 3 months ago | |
What will be the peak annual sales of Cobenfy by end of 2025? | Categorical | | | 3 months ago | |
Region with highest initial sales of Cobenfy (KarXT) in 2024? | Categorical | | | 3 months ago | |
Primary side effect reported for Cobenfy (KarXT) by end of 2024? | Categorical | | | 3 months ago | |
Major company announcing similar schizophrenia drug by end of 2025? | Categorical | | | 3 months ago | |
